Advances in pharmacotherapeutics for hepatocellular carcinoma-Reference-Cited by-同舟云学术

Advances in pharmacotherapeutics for hepatocellular carcinoma

Published:2021-03-03 Issue:10 Volume:22 Page:1343-1354
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Cerrito Lucia¹,Santopaolo Francesco¹,Monti Flavia,Pompili Maurizio¹,Gasbarrini Antonio¹^ORCID,Ponziani Francesca Romana¹

Affiliation:

1. Internal Medicine, Gastroenterology And Hepatology, Fondazione Policlinico Universitario Agostino Gemelli Irccs, Università Cattolica Del Sacro Cuore, ROMA, ITALY

Funder

was not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2021.1892074

Reference118 articles.

1. Hepatocellular Carcinoma

2. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

3. Sorafenib: A Review in Hepatocellular Carcinoma

4. Sorafenib in Advanced Hepatocellular Carcinoma

5. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis;BMC Cancer;2023-10-19

2. Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma;Computational and Mathematical Methods in Medicine;2022-12-17

3. Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives;Cancers;2022-09-23

4. Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs;Frontiers in Pharmacology;2022-06-07

5. The Role of Protein SUMOylation in Human Hepatocellular Carcinoma: A Potential Target of New Drug Discovery and Development;Cancers;2021-11-14